Skip to content

Clinical trials

Phase 3 Atherosclerosis trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 3 Country / region: Austria Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20121
20171
20181
20211
20221
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Amgen2
Novartis Pharmaceuticals2
Boston Scientific Corporation1
CSL Behring1
Medical University of Graz1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis11
Peripheral Arterial Disease3
Cardiovascular Diseases2
Coronary Artery Disease2
Heart Diseases2
Hypercholesterolemia2
Stroke2
Acute Coronary Syndrome1
Arterial Occlusive Diseases1
Atrial Fibrillation1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.